Northland Securities Downgrades Thoratec To Market Perform

Analysts at Northland Securities downgraded Thoratec

from Outperform to Market Perform. The target price for Thoratec has been lowered from $46.00 to $26.00. Thoratec shares have dropped 37.75% over the past 52 weeks, while the S&P 500 index has gained 14.20% in the same period. Thoratec's shares surged 2.33% to close at $23.27 on Friday.